Importantly, however, they state that molecular testing remains preferred, with higher sensitivity during the first 5.5 days after illness onset, and conclude that IgM against SARS-CoV-2 may be useful in suspected COVID-19 patients negative by molecular methods after this time point. This evidence concerns the gene CD40LG and COVID-19.